Oculis Holding AG (FRA:CR5) Accounts Payable & Accrued Expense : €9.87 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Accounts Payable & Accrued Expense?

Oculis Holding AG's quarterly accounts payable & accrued expense declined from Sep. 2023 (€16.03 Mil) to Dec. 2023 (€14.36 Mil) and declined from Dec. 2023 (€14.36 Mil) to Mar. 2024 (€9.87 Mil).

Oculis Holding AG's annual accounts payable & accrued expense increased from Dec. 2021 (€3.72 Mil) to Dec. 2022 (€12.04 Mil) and increased from Dec. 2022 (€12.04 Mil) to Dec. 2023 (€14.36 Mil).

Oculis Holding AG Accounts Payable & Accrued Expense Historical Data

The historical data trend for Oculis Holding AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Accounts Payable & Accrued Expense Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

3.84

3.72

12.04

14.36

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial							-	12.64	16.03	14.36	9.87

Oculis Holding AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Oculis Holding AG (FRA:CR5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

OCS:USA OCS:Iceland

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG (FRA:CR5) Headlines

No Headlines